# Chemours Sells Glycolic Acid Business to PureTech Scientific for $137M

The Chemours Company agreed to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., backed by Iron Path Capital. The transaction is expected to close by Q3 2023.

- Type: Acquisition
- Announced: 2023-06-01
- Where: United States
- Value: $137.0M
- Status: announced
- Products: glycolic acid, alpha hydroxy acids
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Chemours](https://endata.com/companies/4611.md) (target)
- [PureTech Scientific Inc.](https://endata.com/companies/70613.md) (acquirer)
- [Iron Path Capital](https://endata.com/companies/70614.md) (investor)

## Sources

- [ironpathcapital.com](https://ironpathcapital.com/the-chemours-company-agrees-to-sell-glycolic-acid-business-to-iron-path-capital-backed-puretech-scientific-inc-for-137-million/), 2023-06-01: "Creating a better world through the power of our chemistry requires a clear focus on where to play and how to win."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.